Table 1.

Descriptive characteristics of survivors included in the study.

Characteristic	Total	n	Female	n	Male	n
Sex (female/male, %)	42.2/57.8	116
Age (year)	12.1 ± 3.3	116	12.2 ± 3.5	49	12.0 ± 3.2	67
Body mass (kg)	46.6 ± 18.0	116	45.2 ± 18.3	49	47.6 ± 17.9	67
Stature (cm)	147.5 ± 17.1	116	145.3 ± 16.0	49	149.0 ± 17.7	67
Body mass index Z-score	0.9 ± 1.1	116	0.8 ± 1.1	49	1.0 ± 1.2	67
Body mass index (categories, %)
Underweight	3.5	4	6.1	3	1.5	1
Normoweight	61.2	71	65.4	32	58.2	39
Overweight	20.7	24	16.3	8	23.9	16
Obese	14.6	17	12.2	6	16.4	11
Years from peak height velocity	–0.8 ± 2.7	116	0.0 ± 2.9	49	–1.3 ± 2.5	67
Time from treatment completion (year)	5.0 ± 3.8	113	5.2 ± 4.1	48	4.9 ± 3.6	65
Radiotherapy exposure (yes/no, %)	27.6/72.4	116	24.5/75.5	49	29.8/70.2	67
Cancer type (%)
Acute lymphoblastic leukemia	38.8	45	36.7	18	40.3	27
Lymphoma	12.1	14	12.2	6	11.9	8
Central nervous system tumors	9.5	11	10.2	5	9.0	6
Renal tumors	7.8	9	4.1	2	10.5	7
Neuroblastoma	6.9	8	12.2	6	3.0	2
Malignant bone tumors	6.9	8	8.2	4	6.0	4
Histiocytosis	5.2	6	6.1	3	4.5	3
Soft tissue and other extraosseous sarcomas	4.3	5	0.0	0	7.5	5
Retinoblastoma	3.5	4	4.1	2	3.0	2
Hepatic tumors	2.6	3	4.1	2	1.5	1
Other malignant epithelial neoplasms	1.7	2	2.0	1	1.5	1
Unspecified malignant neoplasms	0.9	1	0.0	0	1.5	1

Notes: Data are presented as mean ± SD or as percentage (%), as indicated. Percentage may not add to 100% due to rounding.